Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-04-04Clinical Trial Update: Impact of Probiotics on Children With ADHD [NA]
The clinical trial evaluating probiotics for ADHD in children has completed; results are not reported in the provided information.
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: The Effects of Cannabigerol on Attention-Deficit/Hyperactivity Disorder [Phase 2]
Phase 2 trial evaluating cannabigerol for attention-deficit/hyperactivity disorder is currently recruiting.
-
FDA approval · 2025-04-01FDA Approved: AMPHETAMINE EXTENDED-RELEASE — Supplemental Application (Neos Therapeutics, LP)
The FDA approved a supplemental application for AMPHETAMINE EXTENDED-RELEASE from Neos Therapeutics, LP, updating the product through a supp…
-
CLINICAL_TRIALS research · 2025-04-01Clinical Trial Update: Immunoprofilling of Peripheral Blood Mononuclear Cells in Children With Attention Deficit/Hyperactivity Disorder
Clinical trial evaluating immunoprofiling of peripheral blood mononuclear cells in children with Attention Deficit Hyperactivity Disorder. T…
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Trauma-adapted Yoga in Child & Adolescent Psychiatry. [NA]
A recruiting clinical trial in Sweden evaluating trauma-adapted yoga for children and adolescents with attention-deficit/hyperactivity disor…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-03-28FDA Approved: METHAMPHETAMINE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for methamphetamine hydrochloride from Hikma Pharmaceuticals USA Inc., validating an approved change…
-
FDA approval · 2025-03-28FDA Approved: AMPHETAMINE EXTENDED-RELEASE — Supplemental Application (Neos Therapeutics, LP)
The FDA granted a supplemental approval for AMPHETAMINE EXTENDED-RELEASE from Neos Therapeutics, LP.
-
CLINICAL_TRIALS research · 2025-03-28Clinical Trial Update: Sustained Endogenous Attention Deficits in Attention Deficit Hyperactivity Disorder [NA]
A clinical trial update investigating sustained endogenous attention deficits in attention-deficit/hyperactivity disorder, currently recruit…
-
CLINICAL_TRIALS trial_result · 2025-03-28Clinical Trial Update: Social Virtual-reality on Enhancing Social Interaction Skills in Children With Attention-deficit/Hyperactivity Disorder [NA]
A completed clinical trial from The Hong Kong Polytechnic University evaluated social virtual reality to improve social interaction skills i…
-
CLINICAL_TRIALS trial_result · 2025-03-25Clinical Trial Update: A Novel Device for the Management of ADHD [NA]
Completed clinical trial evaluating a novel device for managing attention-deficit/hyperactivity disorder; results were posted in March 2025.
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: Experimental Research on the Training of Executive Functions Through the APP "The Apollo & Rosetta Adventures" (E-FAR) in Children with ADHD (8-13 Yrs) [NA]
A completed clinical trial evaluating an app-based program to train executive functions in children aged 8-13 with ADHD.
-
CLINICAL_TRIALS research · 2025-03-20Clinical Trial Update: BUILT Family Lifestyle Program for Children with ADHD [NA]
Clinical trial update for the BUILT Family Lifestyle Program for children with Attention-deficit/hyperactivity disorder; the study is curren…
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: Effects of Telepsychiatric Parent Training on Caregivers of Children With ADHD (TPT-ADHD) [NA]
Completed clinical trial evaluating the effects of telepsychiatric parent training on caregivers of children with Attention-Deficit/Hyperact…
-
FDA approval · 2025-03-18FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals,Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for methylphenidate hydrochloride (ANDA204115), a generic ADHD medication.
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: The Effects of an Online Mindfulness-based Intervention for Children with Attention-Deficit/Hyperactivity Disorder [NA]
The clinical trial is evaluating an online mindfulness-based intervention for children with ADHD. Recruitment is ongoing.
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: A Pilot Study of a Blended Intervention Targeting Emotion Dysregulation in Adults With ADHD [NA]
This completed pilot trial evaluated a blended intervention aimed at improving emotion regulation in adults with attention-deficit/hyperacti…
-
CLINICAL_TRIALS research · 2025-03-17Clinical Trial Update: Stimulant Effects on Disruptive Behavior [Phase 4]
Phase 4 clinical trial evaluating the effects of stimulants on disruptive behavior in individuals with Attention Deficit Hyperactivity Disor…
-
CLINICAL_TRIALS research · 2025-03-14Clinical Trial Update: Intervention With Weighted Blankets for Children With ADHD and Sleep Problems: Implementation and Effectiveness [NA]
This clinical trial update describes an intervention using weighted blankets for children with ADHD and sleep problems and highlights implem…
-
FDA approval · 2025-03-13FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for a generic combination of dextroamphetamine and amphetamine salts developed by Camber Pharmaceuti…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Effect of Transcranial Pulse Stimulation on ADHD [NA]
A clinical trial evaluating transcranial pulse stimulation for attention-deficit/hyperactivity disorder has completed; no results are provid…
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: Cognitive Behavior Therapy for Children With Attention Deficit Hyperactivity Disorder [NA]
The clinical trial evaluating cognitive behavior therapy for children with Attention Deficit Hyperactivity Disorder has completed. The snipp…
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: Structured Physical Training with and Without Cognitive Support for Adults with ADHD [NA]
Clinical trial update on structured physical training for adults with ADHD, comparing outcomes with and without cognitive support.
-
EMA approval · 2025-03-11EMA Authorised: Paxneury (guanfacine hydrochloride) — Neuraxpharm Pharmaceuticals S.L.
The European Medicines Agency authorised Paxneury, containing guanfacine hydrochloride, by Neuraxpharm Pharmaceuticals S.L. for attention-de…
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: Assessing Mobile Apps for Adult ADHD [NA]
A clinical trial update notes that a study assessing mobile apps for adults with Attention Deficit Hyperactivity Disorder has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: Effect of Vojta Therapy on Motor Control in Children With Attention Deficit Hyperactivity Disorder [NA]
A completed clinical trial evaluated the effect of Vojta Therapy on motor control in children with Attention-deficit/hyperactivity disorder.…